ZC3HAV1 and liver cancer: 69% of liver cancer tissues showed a low expression level of ZAP compared with non-cancerous tissues, and studies have shown that small-molecule anticancer compounds that directly target the valosin-containing protein are effective and safe to treat liver cancer when used in combination with OV M1 [47].